Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Cell Rep ; 41(11): 111804, 2022 12 13.
Artículo en Inglés | MEDLINE | ID: mdl-36516778

RESUMEN

Fats are essential in healthy diets, but how dietary fats affect immune cell function and overall health is not well understood. Mimicking human high-fat diets (HFDs), which are rich in different fatty acid (FA) components, we fed mice various HFDs from different fat sources, including fish oil and cocoa butter. Mice consuming the fish oil HFD exhibit a hair-loss phenotype. Further studies show that omega-3 (n-3) FAs in fish oil promote atypical infiltration of CD207- (langerin-) myeloid macrophages in skin dermis, which induce hair loss through elevated TNF-α signaling. Mechanistically, epidermal fatty acid binding protein (E-FABP) is demonstrated to play an essential role in inducing TNF-α-mediated hair loss by activating the n-3 FA/ROS/IL-36 signaling pathway in dermal resident macrophages. Absence of E-FABP abrogates fish oil HFD-induced murine hair loss. Altogether, these findings support a role for E-FABP as a lipid sensor mediating n-3 FA-regulated macrophage function and skin health.


Asunto(s)
Ácidos Grasos Omega-3 , Aceites de Pescado , Ratones , Humanos , Animales , Aceites de Pescado/farmacología , Aceites de Pescado/metabolismo , Dieta Alta en Grasa/efectos adversos , Factor de Necrosis Tumoral alfa/metabolismo , Grasas de la Dieta/farmacología , Macrófagos/metabolismo , Proteínas de Unión a Ácidos Grasos/genética , Proteínas de Unión a Ácidos Grasos/metabolismo , Ácidos Grasos Omega-3/metabolismo , Alopecia/metabolismo
2.
Sci Rep ; 6: 26933, 2016 05 27.
Artículo en Inglés | MEDLINE | ID: mdl-27230286

RESUMEN

Male C57BL/6J mice raised on high fat diet (HFD) become prediabetic and develop insulin resistance and sensory neuropathy. The same mice given low doses of streptozotocin are a model of type 2 diabetes (T2D), developing hyperglycemia, severe insulin resistance and diabetic peripheral neuropathy involving sensory and motor neurons. Because of suggestions that increased NAD(+) metabolism might address glycemic control and be neuroprotective, we treated prediabetic and T2D mice with nicotinamide riboside (NR) added to HFD. NR improved glucose tolerance, reduced weight gain, liver damage and the development of hepatic steatosis in prediabetic mice while protecting against sensory neuropathy. In T2D mice, NR greatly reduced non-fasting and fasting blood glucose, weight gain and hepatic steatosis while protecting against diabetic neuropathy. The neuroprotective effect of NR could not be explained by glycemic control alone. Corneal confocal microscopy was the most sensitive measure of neurodegeneration. This assay allowed detection of the protective effect of NR on small nerve structures in living mice. Quantitative metabolomics established that hepatic NADP(+) and NADPH levels were significantly degraded in prediabetes and T2D but were largely protected when mice were supplemented with NR. The data justify testing of NR in human models of obesity, T2D and associated neuropathies.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Neuropatías Diabéticas/prevención & control , Hipoglucemiantes/farmacología , Niacinamida/análogos & derivados , Obesidad/tratamiento farmacológico , Estado Prediabético/tratamiento farmacológico , Animales , Glucemia/metabolismo , Córnea/efectos de los fármacos , Córnea/inervación , Córnea/patología , Diabetes Mellitus Experimental/inducido químicamente , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Experimental/patología , Neuropatías Diabéticas/inducido químicamente , Neuropatías Diabéticas/metabolismo , Neuropatías Diabéticas/patología , Dieta Alta en Grasa , Insulina/sangre , Resistencia a la Insulina , Hígado/efectos de los fármacos , Hígado/metabolismo , Hígado/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Niacinamida/farmacología , Obesidad/etiología , Obesidad/metabolismo , Obesidad/patología , Estado Prediabético/etiología , Estado Prediabético/metabolismo , Estado Prediabético/patología , Compuestos de Piridinio , Estreptozocina
3.
J Neurophysiol ; 114(1): 199-208, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25925322

RESUMEN

The purpose of this study was to determine the effect of supplementing the diet of a mouse model of type 2 diabetes with menhaden (fish) oil or daily treatment with resolvin D1 on diabetic neuropathy. The end points evaluated included motor and sensory nerve conduction velocity, thermal sensitivity, innervation of sensory nerves in the cornea and skin, and the retinal ganglion cell complex thickness. Menhaden oil is a natural source for n-3 polyunsaturated fatty acids, which have been shown to have beneficial effects in other diseases. Resolvin D1 is a metabolite of docosahexaenoic acid and is known to have anti-inflammatory and neuroprotective properties. To model type 2 diabetes, mice were fed a high-fat diet for 8 wk followed by a low dosage of streptozotocin. After 8 wk of hyperglycemia, mice in experimental groups were treated for 6 wk with menhaden oil in the diet or daily injections of 1 ng/g body wt resolvin D1. Our findings show that menhaden oil or resolvin D1 did not improve elevated blood glucose, HbA1C, or glucose utilization. Untreated diabetic mice were thermal hypoalgesic, had reduced motor and sensory nerve conduction velocities, had decreased innervation of the cornea and skin, and had thinner retinal ganglion cell complex. These end points were significantly improved with menhaden oil or resolvin D1 treatment. Exogenously, resolvin D1 stimulated neurite outgrowth from primary cultures of dorsal root ganglion neurons from normal mice. These studies suggest that n-3 polyunsaturated fatty acids derived from fish oil could be an effective treatment for diabetic neuropathy.


Asunto(s)
Antiinflamatorios/farmacología , Diabetes Mellitus Experimental/fisiopatología , Neuropatías Diabéticas/dietoterapia , Neuropatías Diabéticas/tratamiento farmacológico , Ácidos Docosahexaenoicos/farmacología , Aceites de Pescado/administración & dosificación , Animales , Células Cultivadas , Córnea/inervación , Córnea/patología , Diabetes Mellitus Experimental/dietoterapia , Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Experimental/patología , Diabetes Mellitus Tipo 2 , Neuropatías Diabéticas/patología , Neuropatías Diabéticas/fisiopatología , Dieta Alta en Grasa , Suplementos Dietéticos , Ganglios Espinales/efectos de los fármacos , Ganglios Espinales/fisiología , Calor , Hiperalgesia/dietoterapia , Hiperalgesia/tratamiento farmacológico , Hiperalgesia/fisiopatología , Ratones Endogámicos C57BL , Conducción Nerviosa/fisiología , Neuritas/efectos de los fármacos , Neuritas/fisiología , Neuronas/efectos de los fármacos , Neuronas/patología , Neuronas/fisiología , Fármacos Neuroprotectores/farmacología , Células Ganglionares de la Retina/patología , Piel/inervación , Piel/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA